Expression of VEGFR2 Ligand Binding Domain in Pichia pink™ 4 Cells and Evaluation of Its Interactions with VEGF-A165 Receptor Binding Domain-Reference-Cited by-同舟云学术

Expression of VEGFR2 Ligand Binding Domain in Pichia pink™ 4 Cells and Evaluation of Its Interactions with VEGF-A165 Receptor Binding Domain

Published:2024-02-13 Issue: Volume: Page:
ISSN:1073-6085
Container-title:Molecular Biotechnology
language:en
Short-container-title:Mol Biotechnol

Author:

Fathi Zahra,Boojar Masoud Mashhadi Akbar,Sajedi Reza H.,Dehnavi Ehsan,Jahanafrooz Zohreh^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12033-024-01057-1.pdf

Reference24 articles.

1. Fairbrother, W. J., Champe, M. A., Christinger, H. W., Keyt, B. A., & Starovasnik, M. A. (1998). Solution structure of the heparin-binding domain of vascular endothelial growth factor. Structure, 6(5), 637–648.

2. Muller, Y. A., Christinger, H. W., Keyt, B. A., & de Vos, A. M. (1997). The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 Å resolution: multiple copy flexibility and receptor binding. Structure, 5(10), 1325–1338.

3. Muller, Y. A., Li, B., Christinger, H. W., Wells, J. A., Cunningham, B. C., & De Vos, A. M. (1997). Vascular endothelial growth factor: Crystal structure and functional mapping of the kinase domain receptor binding site. Proceedings of the National Academy of Sciences, 94(14), 7192–7197.

4. Uciechowska-Kaczmarzyk, U., Babik, S., Zsila, F., Bojarski, K. K., Beke-Somfai, T., & Samsonov, S. A. (2018). Molecular dynamics-based model of VEGF-A and its heparin interactions. Journal of Molecular Graphics and Modelling, 82, 157–166.

5. Zajkowska, M., Lubowicka, E., Malinowski, P., Szmitkowski, M., & Ławicki, S. (2018). Plasma levels of VEGF-A, VEGF B, and VEGFR-1 and applicability of these parameters as tumor markers in diagnosis of breast cancer. Acta Biochimica Polonica, 65(4), 621–628.